Rupert Sandbrink

Company: Cellerys

Job title: Chief Executive Officer

Seminars:

Establishing Immune Tolerance in Multiple Sclerosis Using Peptide-Coupled Red Blood Cells 3:00 pm

Development and clinical implementation of a GMP process for peptide coupling using red blood cells from individual patients Review of the phase 1b trial including the clinical, safety and immunological data Design and implementation of a phase 2 study for clinical proof-of-conceptRead more

day: Day Two